Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-03

Clinical Trial Update: Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating the efficacy of combining Botulinum toxin type A with oral tadalafil 5 mg in men with erectile dysfunction associated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)
  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Aswan University Hospital | Conditions: Erectile Dysfunction With Diabetes Mellitus | Phase 2, Phase 3 | Status: RECRUITING